scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPHEART.00634.2005 |
P698 | PubMed publication ID | 16199480 |
P50 | author | Zequan Yang | Q57008040 |
Brent A French | Q57233642 | ||
Yaqin Xu | Q63014343 | ||
Marie-Claire Toufektsian | Q63014405 | ||
Susan I Ramos | Q114421965 | ||
P2093 | author name string | Yuqing Huo | |
Ankit D Tejani | |||
Yongguang Ma | |||
P433 | issue | 2 | |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | H692-9 | |
P577 | publication date | 2005-09-30 | |
P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
P1476 | title | Activated platelets contribute importantly to myocardial reperfusion injury | |
P478 | volume | 290 |
Q30421609 | A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice |
Q30301174 | Atorvastatin at reperfusion reduces myocardial infarct size in mice by activating eNOS in bone marrow-derived cells |
Q28086932 | Autophagy, a process within reperfusion injury: an update |
Q47258313 | Cardioprotection--time to take into account clinical complexity: the case of antiplatelet agents : editorial to "two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts" by Xi-Ming Yang et al. |
Q34027137 | Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury. |
Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
Q90260127 | Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC-PPCI randomised controlled trial |
Q94475026 | Effects and Mechanisms of Vitamin C Post-Conditioning on Platelet Activation after Hypoxia/Reoxygenation |
Q38840270 | Effects of prostaglandin E1 on reperfusion injury patients: A meta-analysis of randomized controlled trials |
Q92533414 | Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study |
Q49917885 | Guidelines for Experimental Models of Myocardial Ischemia and Infarction |
Q37464638 | Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets |
Q36082063 | ITF1697, a stable Lys-Pro-containing peptide, inhibits weibel-palade body exocytosis induced by ischemia/reperfusion and pressure elevation |
Q47260770 | Impaired platelet function reduces myocardial infarct size in Galphaq knock-out mice in vivo |
Q36070565 | Mesenchymal stromal cells in renal ischemia/reperfusion injury. |
Q30432468 | Myocardial ischemic memory imaging with molecular echocardiography |
Q52325694 | No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury. |
Q47133234 | Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation |
Q58702398 | Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites |
Q27310589 | Phosphorylation of vasodilator-stimulated phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injury |
Q64970706 | Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. |
Q36763104 | Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts |
Q46148909 | Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors |
Q41240124 | Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury |
Q37996098 | Platelet-mediated vascular dysfunction during acute lung injury |
Q33374023 | Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice |
Q64274965 | Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target |
Q38249957 | Platelets in inflammation and immunity |
Q36893405 | Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice |
Q34458416 | Remote ischemic conditioning. |
Q36233665 | Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation |
Q36975405 | Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease |
Q90633605 | Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation |
Q37357405 | Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats |
Q46774065 | TM-1-1DP exerts protective effect against myocardial ischemia reperfusion injury via AKT-eNOS pathway |
Q88967545 | Targeted repair of heart injury by stem cells fused with platelet nanovesicles |
Q30429069 | Targeting of adenosine receptors in ischemia-reperfusion injury |
Q28513807 | The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi |
Q36883254 | The cardioprotective effects of citric Acid and L-malic Acid on myocardial ischemia/reperfusion injury |
Q35387131 | The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations |
Q47153037 | The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction |
Q30275901 | The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE. |
Q54988971 | Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury. |
Q37277256 | Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts |
Q30423185 | T₂ -weighted MRI of post-infarct myocardial edema in mice |
Q34092872 | eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. |
Search more.